VISWANATHAN SWAMINATHAN: Open Payments
NPI 1376568550 · PLYMOUTHY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 34 payments from 11 companies in 2025. Trend: 2023 $740 · 2024 $818 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $141 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Neurocrine BioSciences, Inc. | 6 | $109 |
| Teva Pharmaceuticals USA, Inc. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: INGREZZA, INVEGA SUSTENNA, ARISTADA, LYBALVI, TRINTELLIX, REXULTI, COBENFY, UZEDY.
Industry payments across NC — which companies pay providers there.
